mab sha31 (SPI Bio Inc)
Structured Review

Mab Sha31, supplied by SPI Bio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mab+sha31/pmc03571390-163-4-7?v=SPI+Bio+Inc
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Prion Propagation and Toxicity Occur In Vitro with Two-Phase Kinetics Specific to Strain and Neuronal Type"
Article Title: Prion Propagation and Toxicity Occur In Vitro with Two-Phase Kinetics Specific to Strain and Neuronal Type
Journal: Journal of Virology
doi: 10.1128/JVI.03082-12
Figure Legend Snippet: Monitoring of PrP aggregates in neurons and astrocytes in CGNC57BL/6 cultures infected with the 139A, ME7, or 22L scrapie strain. (A) Cultures were exposed to 139A-, ME7-, or 22L-infected brain homogenates at a final concentration of 0.01% (wt/vol). At different times postexposure, cells were fixed, permeabilized, and treated with 3 M guanidine thiocyanate. Immunostaining of PrP (in green) was performed by using monoclonal antibody Sha31. DAPI staining appears in blue. CGNC57BL/6 cultures infected with the 139A, ME7, and 22L strains are compared to control cultures (CT). Control and infected CGNC57BL/6 cultures shown in the figure were labeled at 21 dpe. In infected cultures, cells showed punctate fluorescence signals, suggesting intracellular PrP aggregates. In contrast, control cultures showed diffuse, homogenous PrP labeling. (B) Data presented in the box plots show the distribution of the quantified number of intraneuronal PrP aggregates at different days postexposure for each scrapie strain. The number of PrP aggregates per neuron significantly increased during the time course of infection in CGNC57BL/6 cells infected with the 139A, ME7, and 22L strains. In CGNC57BL/6 cells infected with the 22L strain, the variation of the number of PrP aggregates per neuron occurred earlier, as soon as 7 dpe, than with the other strains. The variations observed in ME7-infected CGNC57BL/6 cells were slighter than those observed with the two other strains. (C) Data represented in the box plot show the distribution of the size of intraneuronal PrP aggregates at different days after exposure to each scrapie strain. Regardless of the strain, infected CGNC57BL/6 cells showed a significant decrease in the size of neuronal PrP aggregates. (D) Data presented in the box plots show the distribution of the number of intra-astrocyte PrP aggregates at different days postexposure for each scrapie strain. Regardless of the strain, the number of PrP aggregates per astrocyte did not vary during the time course of infection. Box plots represent data from three independent experiments performed in triplicate ± the standard error of the mean. Differences compared between each point (*) were significant at a P value of ≤0.05.
Techniques Used: Infection, Concentration Assay, Immunostaining, Staining, Labeling, Fluorescence
Figure Legend Snippet: Double immunofluorescence of PrP and organelle markers in CGNC57BL/6 cultures infected with the 139A strain at 21 dpe. Immunolabeled PrP (A, D, G, J, and M) and organelle markers (B, E, H, K, and N) were visualized by confocal microscopy (green and red, respectively). In merged images (C, F, I, L, and O), yellow areas indicate colocalization, and DAPI staining appears in blue. Immunostaining was performed with the following antibodies: Sha31 monoclonal antibody (PrP), giantin monoclonal antibody (Golgi apparatus) (B and C), early endosome autoantigen 1 monoclonal antibody (EEA1) (E and F), lysosome-associated membrane protein 2 monoclonal antibody (LAMP2) (H and I), cathepsin D monoclonal antibody (lysosomal lumen) (K and L), and GRP78 monoclonal antibody (endoplasmic reticulum) (N and O).
Techniques Used: Immunofluorescence, Infection, Immunolabeling, Confocal Microscopy, Staining, Immunostaining
Figure Legend Snippet: Double immunofluorescence of PrP and organelle markers in CGNC57BL/6 cultures infected with the ME7 strain at 21 dpe. Immunolabeled PrP (A, D, G, J, and M) and organelle markers (B, E, H, K, and N) were visualized by confocal microscopy (green and red, respectively). In merged images (C, F, I, L, and O), yellow areas indicate colocalization, and DAPI staining appears in blue. Immunostaining was performed with the following antibodies: Sha31 monoclonal antibody (PrP), giantin monoclonal antibody (Golgi apparatus) (B and C), early endosome autoantigen 1 monoclonal antibody (EEA1) (E and F), lysosome-associated membrane protein 2 monoclonal antibody (LAMP2) (H and I), cathepsin D monoclonal antibody (lysosomal lumen) (K and L), and GRP78 monoclonal antibody (endoplasmic reticulum) (N and O).
Techniques Used: Immunofluorescence, Infection, Immunolabeling, Confocal Microscopy, Staining, Immunostaining
Figure Legend Snippet: Double immunofluorescence of PrP and organelle markers in CGNC57BL/6 cultures infected with the 22L strain at 21 dpe. Immunolabeled PrP (A, D, G, J, and M) and organelle markers (B, E, H, K, and N) were visualized by confocal microscopy (green and red, respectively). In merged images (C, F, I, L, and O), yellow areas indicate colocalization, and DAPI staining appears in blue. Immunostaining was performed with the following antibodies: Sha31 monoclonal antibody (PrP), giantin monoclonal antibody (Golgi apparatus) (B and C), early endosome autoantigen 1 monoclonal antibody (EEA1) (E and F), lysosome-associated membrane protein 2 monoclonal antibody (LAMP2) (H and I), cathepsin D monoclonal antibody (lysosomal lumen) (K and L), and GRP78 monoclonal antibody (endoplasmic reticulum) (N and O).
Techniques Used: Immunofluorescence, Infection, Immunolabeling, Confocal Microscopy, Staining, Immunostaining

